BioDlink International Company Limited (HKG:1875)
Hong Kong · Delayed Price · Currency is HKD 3.625
-0.145 (-3.85%)
Sep 11, 2026, 4:08 PM HKT
HKG:1875 Market Cap
HKG:1875 has a market cap or net worth of 2.91 billion as of September 11, 2026. Its market cap has increased by 57.08% in one year.
Market Cap
2.91B
Enterprise Value
3.02B
Revenue
582.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.63
ChartMarket Cap Chart
Since November 8, 2019, HKG:1875's market cap has decreased from 3.57B to 2.91B, a decrease of -18.35%. That is a compound annual growth rate of -2.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 2.91B | 50.80% |
| Dec 24, 2025 | 1.93B | 39.66% |
| Dec 31, 2024 | 1.38B | -9.14% |
| Dec 29, 2023 | 1.52B | -17.92% |
| Dec 30, 2022 | 1.85B | -29.40% |
| Dec 31, 2021 | 2.63B | -0.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Qyuns Therapeutics | 3.69B |
| Mirxes Holding Company | 3.66B |
| HJ Science | 3.17B |
| Jiangsu Recbio Technology | 3.08B |
| Laekna | 2.87B |
| Medtide | 2.84B |
| Viva Biotech Holdings | 2.78B |
| Clover Biopharmaceuticals | 2.73B |